An enzymatically active chimeric protein containing the hydrophilic form of NADPH-cytochrome p450 reductase fused to the membrane-binding domain of cytochrome b5
被引:17
|
作者:
Gilep, AA
论文数: 0引用数: 0
h-index: 0
机构:Univ Texas, SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA
Gilep, AA
Guryev, OL
论文数: 0引用数: 0
h-index: 0
机构:Univ Texas, SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA
Guryev, OL
Usanov, SA
论文数: 0引用数: 0
h-index: 0
机构:Univ Texas, SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA
Usanov, SA
Estabrook, RW
论文数: 0引用数: 0
h-index: 0
机构:Univ Texas, SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA
Estabrook, RW
机构:
[1] Univ Texas, SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA
cytochrome b5;
cytochrome P450;
NADPH-cytochrome P450 reductase;
chimeric protein;
heterologous expression in E. coli;
affinity chromatography;
electron transfer;
D O I:
10.1006/bbrc.2001.5075
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
The microsomal flavoprotein NADPH-cytochrome P450 reductase (CPR) contains an N-terminal hydrophobic membrane-binding domain required for reconstitution of hydroxylation activities with cytochrome P450s. In contrast, cytochrome b(5) (b(5)) contains a C-terminal hydrophobic membrane-binding domain required for interaction with P450s. We have constructed, expressed and purified a chimeric flavoprotein (hdb5-CPR) where the C-terminal 45 amino acid residues of b(5) have replaced the N-terminal 56 amino acid domain of CPR. This hybrid flavoprotein retains the catalytic properties of the native CPR and is able to reconstitute fatty acid and steroid hydroxylation activities with CYP4A1 and CYP17A. However hdb5-CPR is much less effective than CPR for reconstituting activity with CYP3A4, We conclude that differences on the surface of the P450s reflect unique and specific information essential for the recognition needed to establish reactions of intermolecular electron transfer from the flavoprotein CPR. (C) 2001 Academic Press.
机构:
Univ Michigan, Chem Biol Doctoral Program, Ann Arbor, MI 48109 USA
Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USAUniv Michigan, Chem Biol Doctoral Program, Ann Arbor, MI 48109 USA
Kenaan, Cesar
Shea, Erin V.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USAUniv Michigan, Chem Biol Doctoral Program, Ann Arbor, MI 48109 USA
Shea, Erin V.
Lin, Hsia-lien
论文数: 0引用数: 0
h-index: 0
机构:
Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USAUniv Michigan, Chem Biol Doctoral Program, Ann Arbor, MI 48109 USA
Lin, Hsia-lien
Zhang, Haoming
论文数: 0引用数: 0
h-index: 0
机构:
Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USAUniv Michigan, Chem Biol Doctoral Program, Ann Arbor, MI 48109 USA
Zhang, Haoming
Pratt-Hyatt, Matthew J.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Kansas, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS USAUniv Michigan, Chem Biol Doctoral Program, Ann Arbor, MI 48109 USA
Pratt-Hyatt, Matthew J.
Hollenberg, Paul F.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Michigan, Chem Biol Doctoral Program, Ann Arbor, MI 48109 USA
Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USAUniv Michigan, Chem Biol Doctoral Program, Ann Arbor, MI 48109 USA